Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways The Institute of Biomedical Science (IBMS) is announcing the findings of an independent report showing that the presence of biomedical scientists in the bowel […]

Read More… from Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care

Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways The Institute of Biomedical Science (IBMS) is announcing the findings of an independent report showing that the presence of biomedical scientists in the bowel […]

Read More… from Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care

Kitchen spice inspired wound dressings

Kitchen spices such as turmeric and black pepper could revolutionise wound dressings: Nano-fibres made from everyday kitchen spices are being spun in the biomedical and tissue engineering laboratory at the University of Bradford to create advanced wound dressings. The fibres, which are finer than spider silk, are being made from turmeric, black pepper, curry leaf, cinnamon […]

Read More… from Kitchen spice inspired wound dressings

Kitchen spice inspired wound dressings

Kitchen spices such as turmeric and black pepper could revolutionise wound dressings: Nano-fibres made from everyday kitchen spices are being spun in the biomedical and tissue engineering laboratory at the University of Bradford to create advanced wound dressings. The fibres, which are finer than spider silk, are being made from turmeric, black pepper, curry leaf, cinnamon […]

Read More… from Kitchen spice inspired wound dressings

Limited efficacy of common local anaesthetic

Limited efficacy of common local anaesthetic: Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain. The medication is used as a local anaesthetic, particularly for orthopaedic operations. A research study by MedUni Vienna has now shown the limited effectiveness of the substance. The study has just been […]

Read More… from Limited efficacy of common local anaesthetic

Limited efficacy of common local anaesthetic

Limited efficacy of common local anaesthetic: Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain. The medication is used as a local anaesthetic, particularly for orthopaedic operations. A research study by MedUni Vienna has now shown the limited effectiveness of the substance. The study has just been […]

Read More… from Limited efficacy of common local anaesthetic

Buckling Under The Strain of NHS Waiting Lists

Why Our Knees Are Buckling Under The Strain of NHS Waiting Lists: New report explores the social and economic impact of knee osteoarthritis and the need to welcome treatment innovation via non-invasive alternatives to surgery. Leading orthopaedic experts are lending their voice to a comprehensive, new report [Under Pressure: A Report on the State of […]

Read More… from Buckling Under The Strain of NHS Waiting Lists

Buckling Under The Strain of NHS Waiting Lists

Why Our Knees Are Buckling Under The Strain of NHS Waiting Lists: New report explores the social and economic impact of knee osteoarthritis and the need to welcome treatment innovation via non-invasive alternatives to surgery. Leading orthopaedic experts are lending their voice to a comprehensive, new report [Under Pressure: A Report on the State of […]

Read More… from Buckling Under The Strain of NHS Waiting Lists

Chromatin openness sheds new light on prostate cancer plasticity

Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study from the University of Eastern Finland Institute of Biomedicine suggests that the SIX2 protein may be a possible factor underlying increased plasticity of prostate cancer cells and treatment resistance. Prostate […]

Read More… from Chromatin openness sheds new light on prostate cancer plasticity

Chromatin openness sheds new light on prostate cancer plasticity

Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study from the University of Eastern Finland Institute of Biomedicine suggests that the SIX2 protein may be a possible factor underlying increased plasticity of prostate cancer cells and treatment resistance. Prostate […]

Read More… from Chromatin openness sheds new light on prostate cancer plasticity